Feb 05, 2018
Vermillion Announces the Grant of Two Ovarian Cancer Diagnostic Patents
Dec 19, 2017
Vermillion Appoints Bob Beechey to Newly Created CFO Post
Nov 21, 2017
Vermillion to Present at the 29th Annual Piper Jaffray Healthcare Conference
Nov 20, 2017
ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1
Nov 16, 2017
Vermillion Announces Publication of Foundational Health Economics Study
Nov 08, 2017
Vermillion Reports Third Quarter 2017 Results
Nov 06, 2017
Vermillion to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum
Nov 01, 2017
ASPiRA Labs Announces a Major Coverage Milestone - A 27% Increase in Covered Lives for OVA1
Oct 31, 2017
ASPiRA Labs Announces OVA1 Contract with Louisiana Blue Cross Blue Shield
Oct 27, 2017
ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1®
Oct 02, 2017
ASPiRA Labs Announces In-Network Contract Agreement with HealthNet Federal Services for OVA1®
Aug 31, 2017
Vermillion and ASPiRA Labs Kick Off Ovarian Cancer Awareness Month with 100,000th Patient Test Milestone and Ringing the Nasdaq Opening Bell
Aug 09, 2017
Vermillion Reports Second Quarter 2017 Results
Aug 04, 2017
Vermillion Announces Date Change of Second Quarter 2017 Financial Results and Investor Conference Call
Aug 01, 2017
Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th
Jul 27, 2017
Vermillion to Report Second Quarter 2017 Financial Results and Host Investor Conference Call on August 8th